Unclear Mechanisms

Featured in: Favicon

mdedge.com Favicon

health-reporter.news

Articles

Helping Patients Cut Down on Sodium: Useful Substitutes and Strategies

Jun 11, 2024 | mdedge.com | Brandy L. Winfree |Unclear Mechanisms

Publish date: June 11, 2024 Humans have used salt for centuries, to preserve or cure food before refrigeration was readily available, and even as currency in some cultures. Though modern food preservation efforts have decreased our reliance on salt, we still heavily incorporate it as a flavor enhancer.
Guidelines on Rapid Blood Pressure Reduction in Acute Ischemic Stroke Challenged

May 23, 2024 | mdedge.com | Susan Hughes |Unclear Mechanisms

BASEL, SWITZERLAND — New findings challenge the practice of rapidly lowering blood pressure (BP) in acute ischemic stroke to allow for speedy thrombolysis. The observational cluster study showed that patients treated in hospitals that followed the guideline-recommended practice of rapidly reducing BP did no better — and actually showed a trend toward worse outcomes — than those treated in hospitals that did not lower BP, even though this meant fewer patient received thrombolysis.
From Pharma’s Factories Direct to You

May 7, 2024 | mdedge.com | Unclear Mechanisms |Robert Glatter |Peter Papadakos |Yash Shah

Publish date: May 7, 2024 Pharmaceutical giant Eli Lilly recently announced that its newly approved weight loss medication Zepbound — a glucagon-like peptide 1 receptor agonist (GLP-1 RA) akin to Mounjaro, Ozempic, and Wegovy — will be prescribed by independent telehealth providers on a platform managed by the company itself. The drug can be subsequently shipped direct to consumer (DTC), allowing delivery straight to patients’ homes.
Teleneurology for Suspected Stroke Speeds Treatment

Apr 24, 2024 | mdedge.com | Pauline Anderson |Unclear Mechanisms

Publish date: April 24, 2024 Alerting neurologists via telemedicine that a patient with suspected acute stroke is en route to the hospital significantly enhances the speed at which thrombolysis is administered and increases the number of patients who receive timelier, potentially lifesaving treatment, new research showed.
Heart Failure the Most Common Complication of Atrial Fibrillation, Not Stroke

Apr 18, 2024 | mdedge.com | Diana Swift |Unclear Mechanisms

Publish date: April 18, 2024 FROM BMJThe lifetime risk of atrial fibrillation (AF) increased from 2000 to 2022 from one in four to one in three, a Danish population-based study of temporal trends found.
Antidiabetic Drugs That Lower Stroke Risk Do So By Unclear Mechanisms

Apr 16, 2024 | health-reporter.news | Unclear Mechanisms

— Unlike traditional antidiabetic therapies, which have never been associated with a significant reduction in stroke in a major trial, some of the newer drugs are showing that benefit, but the protection is not linked to tighter glycemic control. In patients with type 2 diabetes mellitus (T2DM), the evidence is strong that “they are not working through glycemic control per se,” according to Larry B. Goldstein, MD, chair of neurology, University of Kentucky School of Medicine, Louisville.
Antidiabetic Drugs That Lower Stroke Risk Do So By Unclear Mechanisms

Apr 15, 2024 | mdedge.com | MDedge Cardiology |Ted Bosworth |Unclear Mechanisms

Publish date: April 15, 2024 — Unlike traditional antidiabetic therapies, which have never been associated with a significant reduction in stroke in a major trial, some of the newer drugs are showing that benefit, but the protection is not linked to tighter glycemic control. In patients with type 2 diabetes mellitus (T2DM), the evidence is strong that “they are not working through glycemic control per se,” according to Larry B.